| Primary |
| Pneumonia |
13.9% |
| Product Used For Unknown Indication |
12.0% |
| Bronchitis |
11.4% |
| Sinusitis |
9.4% |
| Upper Respiratory Tract Infection |
7.7% |
| Cough |
4.3% |
| Respiratory Tract Infection |
4.2% |
| Pseudomonas Infection |
3.8% |
| Infection |
3.7% |
| Oropharyngeal Pain |
3.3% |
| Mycobacterium Avium Complex Infection |
3.1% |
| Nasopharyngitis |
3.1% |
| Pyrexia |
2.9% |
| Ill-defined Disorder |
2.8% |
| Hypertension |
2.7% |
| Chlamydial Infection |
2.4% |
| Prophylaxis |
2.4% |
| Pharyngitis |
2.4% |
| Atrial Fibrillation |
2.2% |
| Ear Infection |
2.2% |
|
| Vomiting |
13.8% |
| Drug Hypersensitivity |
10.6% |
| Drug Ineffective |
7.8% |
| Rash |
7.5% |
| Urticaria |
6.3% |
| Weight Decreased |
5.5% |
| Nausea |
5.4% |
| Tinnitus |
5.4% |
| Diarrhoea |
4.8% |
| Pruritus |
3.4% |
| Hypersensitivity |
3.3% |
| Malaise |
3.3% |
| Dyspnoea |
3.1% |
| Electrocardiogram Qt Prolonged |
3.0% |
| Rhabdomyolysis |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Tremor |
2.8% |
| Pneumonia |
2.7% |
| Deafness |
2.5% |
| International Normalised Ratio Increased |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
26.4% |
| Hiv Infection |
10.8% |
| Drug Use For Unknown Indication |
10.4% |
| Pneumonia |
6.6% |
| Foetal Exposure During Pregnancy |
5.3% |
| Pseudomonas Infection |
4.0% |
| Bronchitis |
3.9% |
| Prophylaxis |
3.8% |
| Hypertension |
3.1% |
| Pyrexia |
3.1% |
| Mycobacterium Avium Complex Infection |
3.0% |
| Cough |
2.9% |
| Sinusitis |
2.8% |
| Upper Respiratory Tract Infection |
2.6% |
| Asthma |
2.4% |
| Mycobacterium Abscessus Infection |
2.3% |
| Infection |
1.8% |
| Pain |
1.7% |
| Respiratory Tract Infection |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
|
| Vomiting |
10.9% |
| Weight Decreased |
10.3% |
| Drug Ineffective |
7.5% |
| Drug Hypersensitivity |
7.0% |
| Stevens-johnson Syndrome |
7.0% |
| Rhabdomyolysis |
5.3% |
| Renal Failure Acute |
4.7% |
| Uveitis |
4.7% |
| Diarrhoea |
4.5% |
| Pancytopenia |
4.2% |
| Urticaria |
4.2% |
| Pyrexia |
3.9% |
| Rash |
3.9% |
| Tinnitus |
3.6% |
| Pneumonia |
3.1% |
| Swelling |
3.1% |
| Tachycardia |
3.1% |
| Thrombocytopenia |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| International Normalised Ratio Increased |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.4% |
| Hiv Infection |
15.5% |
| Drug Use For Unknown Indication |
15.4% |
| Pain |
5.5% |
| Contraception |
5.0% |
| Prophylaxis |
3.1% |
| Asthma |
2.9% |
| Depression |
2.9% |
| Hypertension |
2.8% |
| Premenstrual Syndrome |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Anxiety |
2.1% |
| Cystic Fibrosis |
2.0% |
| Pneumonia |
2.0% |
| Nausea |
1.8% |
| Bronchitis |
1.7% |
| Acne |
1.6% |
| Mycobacterium Avium Complex Infection |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Infection |
1.3% |
|
| Pulmonary Embolism |
14.4% |
| Vomiting |
12.3% |
| Pain |
11.0% |
| Weight Decreased |
8.5% |
| Weight Increased |
5.3% |
| Deep Vein Thrombosis |
4.7% |
| Pneumonia |
4.2% |
| Renal Failure Acute |
4.1% |
| Injury |
3.6% |
| Nausea |
3.5% |
| Anxiety |
3.2% |
| Pyrexia |
3.2% |
| Cholecystitis Chronic |
3.2% |
| Sepsis |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Thrombocytopenia |
2.9% |
| Wheezing |
2.6% |
| Urinary Tract Infection |
2.6% |
| Cholelithiasis |
2.5% |
| Death |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
22.0% |
| Bronchitis |
11.6% |
| Atrial Fibrillation |
8.6% |
| Drug Use For Unknown Indication |
7.7% |
| Hypertension |
6.4% |
| Coronary Artery Disease |
5.7% |
| Rheumatoid Arthritis |
5.2% |
| Ill-defined Disorder |
4.0% |
| Pseudomonas Infection |
4.0% |
| Osteoporosis |
3.0% |
| Pneumonia |
3.0% |
| Tuberculosis |
3.0% |
| Gout |
2.7% |
| Bronchiolitis |
2.2% |
| Lung Transplant |
2.0% |
| Sinusitis |
2.0% |
| Upper Respiratory Tract Infection |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Cystic Fibrosis |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.7% |
|
| Drug Interaction |
26.0% |
| Rhabdomyolysis |
17.0% |
| Electrocardiogram Qt Prolonged |
7.0% |
| Weight Decreased |
6.0% |
| Myalgia |
4.0% |
| Renal Failure Acute |
4.0% |
| Therapeutic Agent Toxicity |
4.0% |
| Torsade De Pointes |
4.0% |
| Blood Creatinine Increased |
3.0% |
| Drug Level Increased |
3.0% |
| Hypersensitivity |
3.0% |
| Hypertension |
3.0% |
| Haemorrhage |
2.0% |
| International Normalised Ratio Increased |
2.0% |
| Multi-organ Failure |
2.0% |
| Oliguria |
2.0% |
| Rash |
2.0% |
| Renal Failure |
2.0% |
| Sedation |
2.0% |
| Sinusitis |
2.0% |
|
